3 Stocks I Plan to Buy If the Stock Market Crashes in 2026
Stock market crashes have presented investors with some spectacular buying opportunities throughout history.The stock market isn't cheap right now. In...
Stock Market
Where Will Uber Technologies Stock Be in 3 Years?
Uber has underperformed the stock market since its 2019 IPO, but that could soon change.Often, when you look up the...
Dow, S&P 500, Nasdaq Mixed; Sandisk, Strategy, MP Materials, Nvidia, Tesla, and Other Movers
The Dow and S&P 500 are now headed for losses for the day.The Dow is down 0.6% while the S&P...
Dow, S&P 500 Fall; Nasdaq Gains; Sandisk, Strategy, MP Materials, Nvidia, Tesla, and Other Movers
The S&P 500 and Dow lost their momentum on Wednesday, closing with their first loss of 2026.The Dow fell 473...
Stock Market Live Jan 7: Sensex, Nifty open in the red amid profit-booking; Titan top gainer
GS on Titan Buy, TP raised to Rs 4850Sharp revenue acceleration to 40% YoY, driven by jewellery:Jewellery growth accelerated sharply from...
Stock Market Today: Dow Tops 49,000 – Barron's
Stock Market Today: Dow Tops 49,000 Barron'sStock market today: Dow, S&P 500, Nasdaq nudge higher after Dow's rally to record Yahoo FinanceGrowth...
Stock market today: Dow crosses 49,000, S&P 500 jumps to new high in record-setting start to year – Yahoo Finance
Stock market today: Dow crosses 49,000, S&P 500 jumps to new high in record-setting start to year Yahoo FinanceStock Market Today:...
Dow Closes Above 49,000; S&P 500 Record; Nasdaq Rises; Nvidia, Chevron, Intel, Palantir, Tesla, More Movers
The Dow Jones Industrial Average finally finished north of 49,000 Tuesday, and the S&P 500 hit a milestone of its...
Stock Market Today, Jan. 6: Micron Technology Surges on AI Memory Demand
AI data centers, tight supply, and bullish analyst targets put this chipmaker in focus, today, Jan. 6, 2026.Today's Change(10.13%) $31.61Current...
Stock Market Today, Jan. 6: Alumis Shares Surge on Positive Phase 3 Psoriasis Data for Envudeucitinib
Investors today are cheering envudeucitinib's Phase 3 edge in oral TYK2 psoriasis as well as Alumis' plans to raise fresh...
